Navigation Links
China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.'s Sales Forecast in Excess of $10,000,000

WEST PALM BEACH, Fla., Aug. 16, 2011 /PRNewswire/ -- China Nuvo Solar Energy, Inc. (OTCQB: CNUV) today announced that SurgLine, Inc. ("SurgLine") and one of its previously announced stocking distributors, OptiMedical Corp. ("OptiMedical") is in the final stages of completing a multi-million dollar order and as a result has revised its forecast to be in excess of $10 million by the end of 2012. Additionally, the Company is negotiating with other stocking distributors and channel sales agreements with third parties regarding additional sales and distribution of the Company's product line.    

Tom Toland, CEO of SurgLine stated, "The stocking distributorship agreement we have in place with OptiMedical Corp. is just one example of how we plan to penetrate the marketplace.  They happen to specialize as a trauma product distributor, and we are confident their sales can reach the $10 million plateau. When you combine the upwardly revised OptiMedical forecasted revenues with our other previously announced agreements we believe we are building the foundation for the future of our Company."  

About SurgLine, Inc.

SurgLine ( sources and distributes high quality FDA approved medical and surgical products at discount prices, thereby reducing or eliminating  the historical brand premium paid by healthcare providers including acute care hospitals, surgery centers, surgical hospital, self insured employers and insurance companies. SurgLine offers high quality medical and surgical supplies and products at substantial savings utilizing stocking distributors and institutional buyers by sourcing products globally without the historical brand premium and industry markup.

About China Nuvo Solar Energy

China Nuvo Solar Energy, Inc. is a development stage company that owns unique patent pending solar and photovoltaic related technology.  The Company is also seeking other business opportunities.

This press release may include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on the Company's current expectations as to future events. However, the forward-looking events and circumstances discussed in this press release might not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

For Further Information Contact:
Henry Fong, President

SOURCE China Nuvo Solar Energy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China Medical Technologies Reports First Fiscal Quarter Financial Results
2. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
3. Concord Medical and GE Healthcare Sign MOU for Preferred Partnership in China
4. China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor
5. China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results
6. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
7. China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
8. China Sky One Medical Announces Second Quarter 2011 Results
9. China Medical Technologies and Leica Microsystems Announce Collaboration
10. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
11. China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23
Post Your Comments:
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that uses pulsed sound ... ... Jim Bertolina, PhD ... Tom Tefft ... device executive Josh Stopek , PhD, who has led R&D and business development teams ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their approach ... patient is doing more than filling out a survey; in many cases health professionals ... emphasis in health care and research on the importance of active engagement with patients ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... ... Lori R. Somekh, founder of the Law Office of Somekh & ... and special needs planning attorneys. “Membership in ElderCounsel helps our office remain up to ... with elder law attorneys nationwide,” said Somekh. , ElderCounsel was founded ...
(Date:10/13/2017)... OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... or dementia. However, many long-term care insurance companies have a waiver for care if ... the 90-day elimination period, when the family pays for care, is often waived, so ...
Breaking Medicine News(10 mins):